Preclinical data and structure described for next-generation TYK2 inhibitor PF-06826647 Aug. 24, 2018
Nuevolution reveals lead discovery program targeting inhibition of IL-17A using small molecules Aug. 23, 2018
Phase III study of MC2-01 cream in psoriasis vulgaris meets primary and secondary endpoints Aug. 21, 2018
Promising phase I results with KY-1005 pave way for phase II evaluation in atopic dermatitis July 30, 2018
RSS